microdosing semaglutide for weight loss People are 'microdosing' weight-loss drugs. A GP explains what to watch out ✨ Microdosing GLP-1: Beyond Weight

Phentermine carries higher cardiovascular risks including elevated heart rate, increased blood pressure, and dependency potential as a Schedule IV controlled substance

Studies evaluating GLP-1 receptor agonists have consistently shown that lean body mass can account for approximately 20% to 40% of total weight reduction

Studies have found that people with type 2 diabetes are more likely to develop Alzheimers disease

Semaglutide dosing follows a carefully structured escalation protocol, and reaching the 0.75mg dose marks a significant threshold in your weight management journey

2 Adults randomly assigned to receive tirzepatide had average weight losses of 16% with 5 mg of the drug, 21.4% with 10 mg, and 22.5% with 15 mg, compared with only 2.4% weight loss with participants who took a placebo